SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000939767-23-000127
Filing Date
2023-12-20
Accepted
2023-12-20 16:20:16
Documents
14
Period of Report
2023-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20231214.htm   iXBRL 8-K 32652
2 EX-3.1 exhibit31amendedandrestate.htm EX-3.1 199727
6 exel-20231214_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-23-000127.txt   535243

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20231214.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20231214_lab.xml EX-101.LAB 25140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20231214_pre.xml EX-101.PRE 13057
8 EXTRACTED XBRL INSTANCE DOCUMENT exel-20231214_htm.xml XML 2905
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 231501521
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)